홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SABS
#3656
SAB Biotherapeutics, Inc. Common Stock
3.9
9
USD
+3.37%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+3.37%
월간 변동
-6.56%
6달 변화
+72.73%
년간 변동율
+197.76%
이전 종가
3.8
6
Open
4.0
0
Bid
Ask
Low
3.9
8
High
4.0
1
양
141
마켓
주식
헬스케어
SABS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
9.29 M
9.29 M
10.41 M
47.61 M
50.95 M
—
Valuation ratios
Enterprise value
26.76 M
10 M
17.39 M
69.14 M
182.58 M
279.1 M
Price to earnings ratio
-1.03
-0.37
-0.44
-0.65
-4.73
-6.19
Price to sales ratio
26.57
31.36
98.4
103.34
—
—
Price to cash flow ratio
-1.02
-0.4
-0.53
-0.72
-5.12
-6.77
Price to book ratio
1.35
0.1
0.17
0.24
1.51
2.02
EBITDA 비율에 대한 기업 가치
-0.71
-0.26
-0.45
-1.73
-3.97
-6.41
Profitability ratios
Return on assets %
-0.26
-0.14
-0.34
0.25
-0.1
-0.32
Return on equity %
-0.44
-0.24
-0.84
0.28
-0.11
-0.92
Return on invested capital %
-186.73
-97.82
-132.16
-110.9
-16.82
-357.7
Gross margin %
100
100
100
100
100
400
Operating margin %
-8 726.26
-45.36 K
-36.15 K
-10.09 K
16.97 K
-74.64 K
EBITDA margin %
-7 991.52
-42.08 K
-33.08 K
-9 432.84
16.27 K
-68.32 K
Net margin %
-9 934.52
-21.88 K
-37.57 K
36.17 K
18.14 K
-5 149.07
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.98
1.69
0.87
10.5
9.46
22.52
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
-0
0
Solvency ratios
Debt to assets ratio
0.01
0.08
0.09
0.02
0.01
0.2
Debt to equity ratio
0.02
0.14
0.23
0.02
0.02
0.41
Long term debt to total assets ratio
-0.01
-0.01
-0.01
0
-0
-0.02
Long term debt to total equity ratio
-0.01
-0.01
-0.02
0
-0
-0.03
Per share metrics
Operating cash flow per share
-1.03
-0.84
-0.77
-0.17
-0.27
-2.05
EBIT per share
-1.08
-1.16
-1.04
-0.16
-0.26
-2.62
EBITDA per share
-0.99
-1.08
-0.96
-0.15
-0.25
-2.43
Total debt per share
0.05
0.32
0.3
0.04
0.04
0.7
Cash per share
2.24
1.38
0.61
1.42
1.57
5
Net current asset value per share
2.57
1.75
1
1.45
1.65
5.86
Tangible book value per share
2.8
2.3
1.29
2.12
2.47
8.19
Working capital per share
1.71
0.71
-0.15
1.32
1.47
3.36
Book value per share
2.8
2.3
1.29
2.12
2.47
8.19
뉴스
H.C. Wainwright, SAB 바이오테라퓨틱스 목표가 7달러로 하향
H.C. Wainwright cuts SAB Biotherapeutics price target to $7 on dilution
SAB 바이오테라퓨틱스, 1상 시험서 초기 C-펩타이드 신호 보고
SAB Biotherapeutics reports early C-peptide signals in phase 1 trial
SAB Biotherapeutics, UBS ’매수’ 등급 개시…당뇨병 치료제 잠재력
SAB Biotherapeutics stock initiated with Buy rating at UBS on diabetes drug potential
구겐하임, SAB 바이오테라퓨틱스에 ’매수’ 등급 제시, T1D 잠재력 주목
Guggenheim initiates SAB Biotherapeutics stock with Buy rating on T1D potential
SAB Biotherapeutics, 이사진 사임 후 이사회 규모 축소
SAB Biotherapeutics reduces board size following resignations of two directors
SAB Biotherapeutics, 주주, 지분 계획 수정안 승인
SAB Biotherapeutics shareholders approve equity plan amendment and Series B conversion proposal